Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Lung Biotechnology PBC
Information provided by (Responsible Party):
ronald oudiz, m.d., Los Angeles Biomedical Research Institute
ClinicalTrials.gov Identifier:
NCT01966302
First received: October 15, 2013
Last updated: May 27, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)